Topic: Mental Health
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Significant chest pain on at least two separate occasions in the past year in which no significant pathology explaining the symptoms was found 2. Signed consent to take part in the study 3. Aged between 16 and 75
Exclusion criteria
Exclusion criteria: Patients who are: 1. Under active psychiatric care 2. Have had a new prescription of a psychoactive drug within the previous two months 3. Receiving, or on waiting list for, a psychological treatment. Those who are currently stable and on regular psychoactive medication (for more than 2 months) are eligible for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in scores on the Health Anxiety Inventory between baseline assessment and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in scores on the Health Anxiety Inventory between baseline assessment and 12 months 2. Change in scores on the Lucock Health Anxiety Questionnaire-Chest Pain version between baseline assessment and 6 months 3. Visual analogue scales for pain and discomfort between baseline assessment and 6 months 4. Schedule for Evaluating Persistent Symptoms (SEPS) between baseline assessment and 6 months 5. Hospital Anxiety and Depression Scale - Anxiety and Depression components between baseline assessment and 6 months 6. Quality of life (EQ-5D) between baseline assessment and 6 months 7. Social functioning (SFQ) between baseline assessment and 6 months 8. Costs using the Adult Service Use Schedule (AD-SUS) between baseline assessment and 6 months | — |
Countries
United Kingdom